Rocket Lab's institutional base is holding and growing, not leaving. Q2 13F filings show BlackRock up 6.8% to about 110 million shares, Vanguard accounts up about 2.4%, State Street up 3.7%, Morgan Stanley up 28.1%, and JPMorgan reported a new position of about 27.5 million shares. Baillie Gifford cut its stake 43.6% amid broader growth-stock rebalancing. Q2 filings predate the Iridium deal announced June 28, so Q3 is the real test of whether big holders back the new strategy. x.com